Report overview
The liver is an essential organ of the body which helps in digestion of food, removal of toxins from the blood, and storage of energy in the body. Inflammation of the liver usually due to viral infections, excessive alcohol consumption, and drugs can cause hepatitis. Hepatitis can be classified as hepatitis A, hepatitis B, hepatitis C, hepatitis D, and hepatitis E through laboratory testing. Acute infection may occur with no symptoms or limited symptoms such as jaundice, dark urine, nausea, extreme fatigue, vomiting, and abdominal pain. People suffering from hepatitis are tested with a range of markers depending on the symptoms exhibited, clinical history, and other tests.
This report contains market size and forecasts of Hepatitis Marker Testing in Global, including the following market information:
Global Hepatitis Marker Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Hepatitis Marker Testing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Hepatitis A Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hepatitis Marker Testing include Becton, Dickinson, Beckman Coulter, Cepheid, BioM?rieux, Bio-Rad Laboratories, Siemens Healthcare, QIAGEN, F. Hoffmann La?Roche and Hologic and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Hepatitis Marker Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hepatitis Marker Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Hepatitis Marker Testing Market Segment Percentages, by Type, 2021 (%)
Hepatitis A
Hepatitis B
Hepatitis C
Hepatitis D
Global Hepatitis Marker Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Hepatitis Marker Testing Market Segment Percentages, by Application, 2021 (%)
Diagnostic Centers
Hospitals
Global Hepatitis Marker Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Hepatitis Marker Testing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hepatitis Marker Testing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Hepatitis Marker Testing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Becton, Dickinson
Beckman Coulter
Cepheid
BioM?rieux
Bio-Rad Laboratories
Siemens Healthcare
QIAGEN
F. Hoffmann La?Roche
Hologic
Thermo Fisher Scientific
